Results 271 to 280 of about 144,583 (352)
Summary Chronic stress, characterized by increased long‐term exposure to the glucocorticoid hormone cortisol, is increasingly linked to obesity development. Still, various knowledge gaps persist, including on underlying pathophysiological mechanisms. The aim of the current review is to provide the latest insights on the connection between stress and ...
Robin Lengton +4 more
wiley +1 more source
Effects of Vitamin E Administration on the Anterior Pituitary of the Castrated Mouse
Kazuo Sakakura
openalex +2 more sources
Abstract Background Metformin and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) may reduce the risk of adiposity‐related cancers in patients with type 2 diabetes (T2D). The potential synergistic effects of these treatments on cancer incidence remain unclear, considering their distinct biological mechanisms and their associated effects on body ...
Alex E. Henney +6 more
wiley +1 more source
Mental stress as a trigger of cardiovascular events: A narrative review
Stress stimulates the prefrontal cortex that in turns activates the limbic system with subsequent activation of the autonomic nervous system. The autonomic nervous system then stimulates the heart, vessels, endocrine and immune systems with a bidirectional communication. These mechanisms increase heart rate and blood pressure, promote vasoconstriction,
Paolo Raggi
wiley +1 more source
Clinical evaluation of determinations of free and serum protein bound triiodthyronine (dextran gel filtration) [PDF]
Heinze, H. G. +3 more
core
ABSTRACT Objectives Although Advancements in the Treatment of Hemoglobinopathies have Considerably Increased Life Expectancy, Hormonal and Pubertal Development Have Been Continuously Affected by Complications From Transfusion‐Related Iron Overload and Cytotoxic Therapies.
J. Dülberg +20 more
wiley +1 more source
Summary Background Pituitary pars intermedia dysfunction (PPID) is commonly treated with pergolide mesylate, a dopamine receptor agonist. Cabergoline is a dopamine receptor agonist that has shown activity on prolactin secretion in horses for up to 10 days.
H. Hess +5 more
wiley +1 more source

